FdaApplication
NDA 217927
Identifiers
- fda_app_no: NDA217927
Properties
| Property | Value |
|---|---|
| applicant_name | SOLUBIOMIX LLC |
| application_type | NDA |
| approval_date | 2023-10-20 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| COXANTO | OXAPROZIN | 300MG | CAPSULE;ORAL |
1 product